Treace Medical Concepts, Inc. TMCI
NASDAQ · United States · Health Technology
$4.39+0.06 (+1.39%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-07 | -0.24 | -0.30 | +19.5% | $45.38M | +3.1% | +6.6%$4.38→$4.67 |
| Q1 2026 | 2026-05-08 | -0.12 | -0.31 | +61.3% | — | — | +1.0%$1.92→$1.94 |
| Q4 2025 | 2026-02-27 | -0.08 | -0.14 | +42.9% | — | — | -21.0%$2.10→$1.66 |
| Q3 2025 | 2025-11-06 | -0.26 | -0.28 | +7.1% | — | — | -28.6%$6.25→$4.47 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.